Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033.

Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world.

Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to produce unique products or product line extensions.

During the projection period, Asia Pacific is expected to be the most profitable market. The Asia Pacific region has a large population, which is marked by increased diabetic awareness, increased awareness of the availability of continuous glucose monitoring devices, and rising consumer healthcare spending. In addition, increased diagnostic lab penetration in the region is likely to fuel demand for continuous glucose monitoring devices over the projection period.

As a consequence of favourable government policies, countries such as China, India, South Korea, and Indonesia are drawing FDIs in the healthcare sector, which is expected to drive the region's continuous glucose monitoring device market.

Competitive Landscape

The Continuous Glucose Monitoring Device Market is highly competitive, with a handful of companies holding a significant share. The key players in the market include A. Menarini Diagnostics, Echo Therapeutics, Inc., Abbott Laboratories, Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, GlySens Incorporated, Insulet Corporation, Johnson & Johnson, LifeScan, Medtronic plc, Medtrum Technologies, Inc., Microchip Technology Inc., Micron Technology Inc., Nemaura Medical, Inc., Novo Nordisk, NXP Semiconductors, Qualcomm, Roche Diagnostics, Senseonics Holdings, Inc., STMicroelectronics, and Tandem Diabetes Care.

Browse More@ https://www.futuremarketinsights.com/reports/continuous-glucose-monitoring-device-market

Market Segments Covered in Continuous Glucose Monitoring Device Industry Analysis
By Component:

  • Transmitters
  • Sensors
  • Receivers

By End-Use:

  • Hospitals
  • Home Care
  • Other End-uses

Comments

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Global Medical face shield Market Insights and Outlook 2022-2032

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies